6.5年纵向随访中疾病活动度与心理健康对炎症性肠病预后的相对贡献
研究纳入760例炎症性肠病成人患者,基线记录焦虑抑郁评分及临床/生化活动度,随访6.5年。多变量Cox回归显示,临床活动且伴常见精神障碍症状者激素处方或 flare、升级治疗、死亡风险显著升高;生化活动且伴精神症状者住院和死亡风险亦显著升高。作者认为心理因素是不良预后的重要决定因素,应作为治疗靶点。
要点
- 临床活动且伴常见精神障碍症状者,激素处方或 flare 风险 HR 2.36,死亡风险 HR 4.99。
- 生化活动且伴常见精神障碍症状者,住院风险 HR 3.10,死亡风险 HR 6.26。
- 仅临床缓解伴精神症状或仅临床活动无精神症状者,风险未显著升高。
核心结论
- 心理因素是炎症性肠病不良预后结局的重要决定因素,应被视为治疗靶点。
研究设计与样本
- 纵向随访研究,基线记录760例炎症性肠病成人的 demographics、亚型、治疗及焦虑抑郁评分,临床活动度用经验证评分系统判定。
- 379例(49.9%)患者检测粪便钙卫蛋白,≥250 μg/g 定义为生化活动。
- 随访6.5年,评估激素处方或 flare、治疗升级、住院、肠切除或死亡,按基线疾病缓解或活动与否及有无常见精神障碍症状分为4组,用多变量Cox回归比较。
主要发现
- 718例(94.5%)参与者提供数据。
- 与基线临床缓解且无常见精神障碍症状者相比,临床活动且伴常见精神障碍症状者激素处方或 flare(HR 2.36;95%CI 1.58-3.54)、治疗升级(HR 1.65;95%CI 1.14-2.40)和死亡(HR 4.99;95%CI 1.80-13.88)显著更高。
- 基线临床缓解且伴常见精神障碍症状者或临床活动但无常见精神障碍症状者,发生率未显著升高。
- 生化活动且伴常见精神障碍症状者,激素处方或 flare(HR 2.48;95%CI 1.38-4.46)、治疗升级(HR 2.97;95%CI 1.74-5.06)、住院(HR 3.10;95%CI 1.43-6.68)和死亡(HR 6.26;95%CI 2.23-17.56)显著更高。
临床怎么用
- 作者认为心理因素是炎症性肠病不良预后的重要决定因素,应被视为治疗靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Symptoms of common mental disorders, such as anxiety or depression, are common in inflammatory bowel disease (IBD) and may affect prognosis. However, unlike clinical or biochemical markers of disease activity, psychological health is not a recommended therapeutic target. We assessed relative contribution of poor psychological health and clinical or biochemical activity to prognosis. METHODS: Demographic features, IBD subtype, treatments, and anxiety and depression scores were recorded at baseline for 760 adults, with clinical activity determined using validated scoring systems. Fecal calprotectin was analyzed in 379 (49.9%) patients (≥250 μg/g used to define biochemical activity). Glucocorticosteroid prescription or flare, escalation, hospitalization, intestinal resection, or death were assessed during 6.5 years of follow-up. Occurrence was compared using multivariate Cox regression across 4 patient groups according to presence of disease remission or activity, with or without symptoms of a common mental disorder, at baseline. RESULTS: In total, 718 (94.5%) participants provided data. Compared with clinical remission without symptoms of a common mental disorder at baseline, need for glucocorticosteroid prescription or flare (hazard ratio [HR], 2.36; 95% confidence interval [CI], 1.58-3.54), escalation (HR, 1.65; 95% CI, 1.14--2.40), and death (HR, 4.99; 95% CI, 1.80-13.88) were significantly higher in those with clinical activity and symptoms of a common mental disorder. Rates in those with clinical remission and symptoms of a common mental disorder at baseline or those with clinical activity without symptoms of a common mental disorder were not significantly higher. Similarly, with biochemical activity and symptoms of a common mental disorder, rates of glucocorticosteroid prescription or flare (HR, 2.48; 95% CI, 1.38-4.46), escalation (HR, 2.97; 95% CI, 1.74-5.06), hospitalization (HR, 3.10; 95% CI, 1.43-6.68), and death (HR, 6.26; 95% CI, 2.23-17.56) were significantly higher. CONCLUSIONS: Psychological factors are important determinants of poor prognostic outcomes in IBD and should be considered as a therapeutic target.
引用
- Fairbrass KM, Gracie DJ, Ford AC, et al. Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 Years of Longitudinal Follow-Up. Gastroenterology. 2022. PMID: 35339461. doi:10.1053/j.gastro.2022.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。